查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1901547

核酸擴增檢測市場：按類型、應用、最終用途、國家和地區分類 - 全球產業分析、市場規模、市場佔有率及2024-2032年預測

Nucleic Acid Amplification Testing Market, By Type, By Application, By End-use, By Country, and By Region - Global Industry Analysis, Market Size, Market Share & Forecast from 2024-2032
出版日期: | 出版商: AnalystView Market Insights | 英文 399 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

2024 年核酸擴增檢測市場規模為 98.9745 億美元，從 2025 年到 2032 年將以 9.5% 的複合年成長率成長。

核酸擴增檢測（NAAT）市場正經歷強勁的全球成長，這主要得益於全球傳染病流行率的上升以及分子診斷技術的不斷進步。 NAAT 是一種高靈敏度技術，是檢測和定量核酸（DNA 或 RNA）的黃金標準，在診斷 COVID-19、HIV 和結核病等疾病方面至關重要。對快速、分散式即時檢測（POC​​）日益成長的需求，以及 NAAT 在腫瘤學和個人化醫療領域應用的不斷擴展，是推動市場擴張的關鍵因素。

核酸擴增檢測市場—市場動態

傳染病和公共衛生危機日益增多

包括呼吸道感染、性傳染感染（STI）以及新興或再發病原體在內的傳染病日益流行，為全球公共衛生系統帶來了嚴峻挑戰，而全球化、都市化和氣候變遷等因素加劇了這一趨勢。例如，根據世界衛生組織（世衛組織）統計，2023年全球約有1,080萬人患有結核病（TB），其中包括600萬男性、360萬名女性和130萬名兒童。為此，核酸擴增檢測（NAAT）的應用變得至關重要，這主要歸功於其高靈敏度和特異性，即使在症狀出現之前也能早期發現感染。早期識別有助於及時治療，有效降低不良健康後果和傳播率，尤其是在性傳染感染方面。此外，NAAT在公共衛生監測中也發揮關鍵作用，能夠在疫情爆發期間進行快速檢測，有助於控制疾病傳播。其檢測新病原體的適應性對於應對公共衛生突發事件至關重要，凸顯了將 NAAT 納入常規衛生策略的必要性，以加強應對傳染病的準備和資源分配。

核酸擴增檢測市場區隔分析：

全球核酸擴增檢測市場按類型、應用、最終用途和地區進行細分。

根據類型，市場可分為聚合酶鍊式反應 (PCR) 檢測、等溫核酸擴增技術 (INAAT) 檢測和其他檢測。 PCR 檢測因其高靈敏度、多功能性以及在診斷和研究應用中的廣泛使用而佔據最大市場佔有率，而 INAAT 檢測則因其快速處理和適用於即時檢測而日益受到關注。

根據應用領域，市場可分為傳染病檢測、腫瘤檢測、遺傳及粒線體疾病檢測和其他應用。由於病毒和細菌感染的日益普及、對精準診斷解決方案的需求不斷成長以及分子檢測在臨床實驗室的廣泛應用，傳染病檢測佔據了最大的市場佔有率。

根據最終用途，市場可分為中心實驗室和參考實驗室、即時檢測機構、生物技術和製藥公司、學術和研究機構以及其他機構。中心實驗室和參考實驗室憑藉其廣泛的檢測服務以及對診斷準確性和可靠性的承諾，佔據了相當大的市場佔有率。隨著對能夠促進快速臨床決策的即時診斷解決方案的需求不斷成長，尤其是在急診和偏遠地區的醫療環境中，即時檢測機構正經歷快速成長。

核酸擴增檢測市場—地域洞察

核酸擴增檢測市場主要由北美地區驅動，該地區憑藉先進的醫療基礎設施、大量的研發投入以及高傳染病發病率，佔據了最大的市場佔有率。緊隨其後的是亞太地區，該地區正經歷著顯著成長，這主要得益於不斷成長的醫療支出、對精準診斷解決方案日益成長的需求以及不斷擴大的人口及其面臨的各種健康挑戰。歐洲則位居第三，受益於其完善的醫療體系和對分子診斷的強而有力的監管支持。拉丁美洲（LATAM）也在成長，儘管成長較慢，但醫療服務可及性的提高和傳染病意識的增強推動了市場的擴張。最後，中東和非洲（MEA）地區面臨醫療資源有限等挑戰，但改善醫療基礎設施和提高疾病意識的努力正在逐步促進市場成長。整體而言，全球市場分佈反映了不同地區醫療成熟度和診斷技術投資水準的差異。

核酸擴增檢測市場—國家概況

美國是核酸擴增檢測 (NAAT) 的主導市場，這主要得益於其先進的醫療保健基礎設施、大量的研發投入以及高傳染病發病率。精準快速診斷解決方案的需求推動了 NAAT 在臨床實驗室、醫院和即時檢測機構的廣泛應用。此外，美國擁有健全的監管框架，為創新診斷技術的發展提供了支持。其他值得關注的市場包括加拿大和墨西哥，這兩個市場也因醫療保健支出增加和分子診斷意識的提高而呈現成長態勢，共同構成了北美市場的蓬勃發展。

目錄

第1章：核酸擴增檢測市場概覽

  • 研究範圍
  • 市場估算年份

第2章：執行概要

  • 市集
  • 競爭洞察

第3章：核酸擴增檢測主要市場趨勢

  • 市場促進因素
  • 市場限制
  • 市場機遇
  • 市場未來趨勢

第4章：核酸擴增檢測產業研究

  • PEST分析
  • 波特五力分析
  • 成長前景分析
  • 規範架構分析

第5章：核酸擴增檢驗市場：地緣政治緊張局勢升級的影響

  • 新冠疫情的影響
  • 俄烏戰爭的影響
  • 中東衝突的影響

第6章：核酸擴增檢測市場概況

  • 核酸擴增檢測市佔率分析，2024年
  • 主要製造商細分數據
    • 知名球員分析
    • 新興參與者分析

第7章：核酸擴增檢驗市場：依類型分類

  • 概述
    • 細分市場佔有率分析：按類型
    • 聚合酶鍊式反應（PCR）檢測
    • 等溫核酸擴增技術（INAAT）檢測
    • 其他

第8章：核酸擴增檢測市場：依應用領域分類

  • 概述
    • 細分市場佔有率分析：按應用
    • 傳染病檢測
    • 腫瘤檢測
    • 基因和粒線體疾病檢測
    • 其他

第9章：核酸擴增檢驗市場：依最終用途分類

  • 概述
    • 細分市場佔有率分析：依最終用途
    • 傳染病檢測
    • 腫瘤檢測
    • 基因和粒線體疾病檢測
    • 其他

第10章：核酸擴增檢驗市場：依地域分類

  • 介紹
  • 北美洲
    • 概述
    • 北美主要製造商
    • 美國
    • 加拿大
  • 歐洲
    • 概述
    • 歐洲主要製造商
    • 德國
    • 英國
    • 法國
    • 義大利
    • 西班牙
    • 荷蘭
    • 瑞典
    • 俄羅斯
    • 波蘭
    • その他
  • 亞太地區
    • 概述
    • 亞太地區主要製造商
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲
    • 印尼
    • 泰國
    • 菲律賓
    • その他
  • 拉丁美洲
    • 概述
    • 拉丁美洲主要製造商
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥倫比亞
    • その他
  • 中東和非洲（MEA）
    • 概述
    • 中東和非洲的主要製造商
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 以色列
    • 土耳其
    • 阿爾及利亞
    • 埃及
    • その他

第11章：主要供應商分析：核酸擴增檢測產業

  • 競爭格局分析
    • Competitive Benchmarking
    • Competitive Positioning
  • 公司簡介
    • Roche (F. Hoffmann-La Roche Ltd.)
    • Abbott Laboratories
    • Thermo Fisher Scientific Inc.
    • bioMerieux
    • Hologic
    • QIAGEN
    • Bio-Rad Laboratories
    • Danaher
    • Grifols SA
    • Seegene Inc.
    • Others

第12章：全面展望

簡介目錄
Product Code: ANV5866

The Nucleic Acid Amplification testing Market size was valued at US$9,897.45 Million in 2024, expanding at a CAGR of 9.5% from 2025 to 2032.

The Nucleic Acid Amplification Testing market is experiencing robust global growth driven by the rising prevalence of infectious diseases worldwide and continuous technological advancements in molecular diagnostics. NAAT, a highly sensitive technique, is the gold standard for detecting and quantifying nucleic acids (DNA or RNA) and is vital in diagnosing conditions such as COVID-19, HIV, and Tuberculosis. The growing demand for rapid, decentralized Point-of-Care (POC) testing and the increasing application of NAAT in oncology and personalized medicine are key factors propelling market expansion.

Nucleic Acid Amplification testing Market- Market Dynamics

Rising Prevalence of Infectious Diseases and Public Health Crises

The rising prevalence of infectious diseases, including respiratory infections, sexually transmitted infections (STIs), and newly emerging or re-emerging pathogens, presents significant challenges for global public health systems, driven by factors such as globalization, urbanization, and climate change, For instance, according to the World Health Organization (WHO), approximately 10.8 million people were reported to have fallen ill with Tuberculosis (TB) globally in 2023, encompassing 6.0 million men, 3.6 million women, and 1.3 million children . In response, the adoption of Nucleic Acid Amplification Tests (NAAT) has become essential, primarily due to its high sensitivity and specificity, which facilitate early detection of infections even before symptoms appear. This early identification enables timely treatment, effectively minimizing adverse health outcomes and transmission rates, especially in the case of STIs. Moreover, NAAT plays a crucial role in public health surveillance, allowing for rapid testing during outbreaks and thereby aiding in the control of disease spread. Its adaptability to detect new pathogens is vital for responding to public health emergencies, underscoring the need for integrating NAAT into routine health strategies to enhance preparedness and resource allocation in combating infectious diseases.

Nucleic Acid Amplification testing Market- Segmentation Analysis:

The Global Nucleic Acid Amplification testing Market is segmented on the basis of Type, Application, End-use, and Region.

Based on Type, the market is divided into Polymerase Chain Reaction (PCR) Tests, Isothermal Nucleic Acid Amplification Technology (INAAT) Tests, and Others. PCR tests hold the largest share due to their high sensitivity, versatility, and widespread use in diagnostic and research applications, while INAAT tests are gaining traction for their rapid processing and suitability for point-of-care testing.

Based on Application, the market is divided into Infectious Disease Testing, Oncology Testing, Genetic & Mitochondrial Disease Testing, and Other Applications. Infectious disease testing accounts for the largest market share due to the rising prevalence of viral and bacterial infections, increasing demand for accurate diagnostic solutions, and widespread adoption of molecular testing in clinical laboratories.

Based on end use the market is divided into Central and Reference Laboratories, Point-of-Care Settings, Biotechnology & Pharmaceutical Companies, and Academic & Research Institutes and others. Central and reference laboratories account for a significant share due to their extensive testing services and commitment to accuracy and reliability in diagnostics. Point-of-care settings are experiencing rapid growth as demand increases for immediate diagnostic solutions that facilitate prompt clinical decision-making, particularly in urgent and remote care environments.

Nucleic Acid Amplification testing Market- Geographical Insights

The Nucleic Acid Amplification Testing market is predominantly driven by North America, which holds the largest share due to advanced healthcare infrastructure, significant investment in research and development, and a high prevalence of infectious diseases. Following North America, the Asia Pacific region is experiencing substantial growth, propelled by rising healthcare expenditures, increasing demand for accurate diagnostic solutions, and a growing population with diverse health challenges. Europe ranks next, benefiting from robust healthcare systems and strong regulatory support for molecular diagnostics. Latin America (LATAM) is also witnessing growth, although at a slower pace, as improvements in healthcare access and rising awareness of infectious diseases contribute to the market's expansion. Lastly, the Middle East and Africa (MEA) region faces challenges such as limited healthcare resources, but efforts to enhance healthcare infrastructure and increasing disease awareness are gradually fostering market growth. Overall, the global distribution reflects varying levels of healthcare maturity and investment in diagnostic technologies.

Nucleic Acid Amplification testing Market- Country Insights

The United States is the dominant market for Nucleic Acid Amplification Testing (NAAT), driven by its advanced healthcare infrastructure, significant investment in research and development, and a high incidence of infectious diseases. The demand for accurate and rapid diagnostic solutions has fostered widespread adoption of NAAT across clinical laboratories, hospitals, and point-of-care settings. Additionally, the U.S. benefits from a strong regulatory framework that supports innovative diagnostic technologies. Other notable markets include Canada and Mexico, which are also experiencing growth due to increasing healthcare expenditures and rising awareness of molecular diagnostics, contributing to a robust North American market landscape.

Nucleic Acid Amplification testing Market- Competitive Landscape:

The Nucleic Acid Amplification Testing (NAAT) market is highly competitive, featuring key players like Roche, Abbott Laboratories, and Thermo Fisher Scientific, known for their innovative diagnostic solutions and extensive product portfolios. bioMerieux and Hologic focus on infectious disease testing, enhancing their market presence through advanced technologies and strategic partnerships. QIAGEN and Bio-Rad Laboratories emphasize assay development and molecular diagnostics, while Danaher leverages its strong R&D capabilities to drive growth. Grifols S.A. and Seegene Inc. are also making strides in the market, contributing unique technologies and expanding their geographical reach, thereby intensifying competition and fostering innovation in NAAT applications. These companies emphasize technological innovation, expansion of product portfolios, and strategic partnerships to enhance their global footprint. For instance, In July 2025, South Korea-based Seegene Inc. launched its CURECA fully automated PCR testing system alongside its STAgora data analytics platform. CURECA is notable as the world's first system to completely automate the entire PCR testing process, which includes everything from sample storage and pre-treatment to nucleic acid extraction, amplification, and final result analysis, requiring no human intervention. Seegene states that the introduction of these new technologies represents a transformative shift in the global diagnostics paradigm.

Recent Developments:

In September 2024 Takara Bio USA, Inc. introduced the SmartChip ND Real-Time PCR System, an automated, high-throughput quantitative PCR (qPCR) solution designated for research-use-only (RUO). This system is designed specifically for monitoring antimicrobial resistance (AMR), addressing the increasing global need for advanced tools in environmental safety and sustainability research.

In December 2025 Roche introduced the cobas BV/CV Assay, a new PCR-based diagnostic test that has received the CE Mark for use in accepting countries. This assay is designed to streamline the diagnostic workflow for vaginitis by utilizing a single vaginal swab to rapidly and accurately detect the bacteria responsible for bacterial vaginosis and the yeast associated with candida vaginitis.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL NUCLEIC ACID AMPLIFICATION TESTING MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • Roche (F. Hoffmann-La Roche Ltd.)
  • Abbott Laboratories
  • Thermo Fisher Scientific Inc.
  • bioMerieux
  • Hologic
  • QIAGEN
  • Bio-Rad Laboratories
  • Danaher
  • Grifols S.A.
  • Seegene Inc.
  • Others

GLOBAL NUCLEIC ACID AMPLIFICATION TESTING MARKET, BY TYPE - MARKET ANALYSIS, 2019 - 2032

  • Polymerase Chain Reaction (PCR) Tests
  • Isothermal Nucleic Acid Amplification Technology (INAAT) Tests
  • Others

GLOBAL NUCLEIC ACID AMPLIFICATION TESTING MARKET, BY APPLICATION - MARKET ANALYSIS, 2019 - 2032

  • Infectious Disease Testing
  • Oncology Testing
  • Genetic & Mitochondrial Disease Testing
  • Others

GLOBAL NUCLEIC ACID AMPLIFICATION TESTING MARKET, BY END-USE - MARKET ANALYSIS, 2019 - 2032

  • Central and Reference Laboratories
  • Point-of-Care Settings
  • Biotechnology & Pharmaceutical Companies
  • Academic & Research Institutes
  • Others

GLOBAL NUCLEIC ACID AMPLIFICATION TESTING MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • The Netherlands
  • Sweden
  • Russia
  • Poland
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Australia
  • Indonesia
  • Thailand
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • UAE
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Nucleic Acid Amplification Testing Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Nucleic Acid Amplification Testing Market Snippet by Type
    • 2.1.2. Nucleic Acid Amplification Testing Market Snippet by Application
    • 2.1.3. Nucleic Acid Amplification Testing Market Snippet by End-use
    • 2.1.4. Nucleic Acid Amplification Testing Market Snippet by Country
    • 2.1.5. Nucleic Acid Amplification Testing Market Snippet by Region
  • 2.2. Competitive Insights

3. Nucleic Acid Amplification Testing Key Market Trends

  • 3.1. Nucleic Acid Amplification Testing Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Nucleic Acid Amplification Testing Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Nucleic Acid Amplification Testing Market Opportunities
  • 3.4. Nucleic Acid Amplification Testing Market Future Trends

4. Nucleic Acid Amplification Testing Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Nucleic Acid Amplification Testing Market: Impact of Escalating Geopolitical Tensions

  • 5.1. Impact of COVID-19 Pandemic
  • 5.2. Impact of Russia-Ukraine War
  • 5.3. Impact of Middle East Conflicts

6. Nucleic Acid Amplification Testing Market Landscape

  • 6.1. Nucleic Acid Amplification Testing Market Share Analysis, 2024
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Nucleic Acid Amplification Testing Market - By Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Type, 2024&2032 (%)
    • 7.1.2. Polymerase Chain Reaction (PCR) Tests
    • 7.1.3. Isothermal Nucleic Acid Amplification Technology (INAAT) Tests
    • 7.1.4. Others

8. Nucleic Acid Amplification Testing Market - By Application

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Application, 2024&2032 (%)
    • 8.1.2. Infectious Disease Testing
    • 8.1.3. Oncology Testing
    • 8.1.4. Genetic & Mitochondrial Disease Testing
    • 8.1.5. Others

9. Nucleic Acid Amplification Testing Market - By End-use

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By End-use, 2024&2032 (%)
    • 9.1.2. Infectious Disease Testing
    • 9.1.3. Oncology Testing
    • 9.1.4. Genetic & Mitochondrial Disease Testing
    • 9.1.5. Others

10. Nucleic Acid Amplification Testing Market- By Geography

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Geography, 2024&2032 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. Nucleic Acid Amplification Testing Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Billion)
    • 10.2.4. North America Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
    • 10.2.5. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
    • 10.2.6. North America Market Size and Forecast, By End-use, 2019 - 2032 (US$ Billion)
    • 10.2.7. U.S.
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.2.7.3. U.S. Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
      • 10.2.7.4. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
      • 10.2.7.5. U.S. Market Size and Forecast, By End-use, 2019 - 2032 (US$ Billion)
    • 10.2.8. Canada
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.2.8.3. Canada Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
      • 10.2.8.4. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
      • 10.2.8.5. Canada Market Size and Forecast, By End-use, 2019 - 2032 (US$ Billion)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. Nucleic Acid Amplification Testing Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Billion)
    • 10.3.4. Europe Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
    • 10.3.5. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
    • 10.3.6. Europe Market Size and Forecast, By End-use, 2019 - 2032 (US$ Billion)
    • 10.3.7. Germany
      • 10.3.7.1. Overview
      • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.3.7.3. Germany Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
      • 10.3.7.4. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
      • 10.3.7.5. Germany Market Size and Forecast, By End-use, 2019 - 2032 (US$ Billion)
    • 10.3.8. UK
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.3.8.3. UK Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
      • 10.3.8.4. UK Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
      • 10.3.8.5. UK Market Size and Forecast, By End-use, 2019 - 2032 (US$ Billion)
    • 10.3.9. France
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.3.9.3. France Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
      • 10.3.9.4. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
      • 10.3.9.5. France Market Size and Forecast, By End-use, 2019 - 2032 (US$ Billion)
    • 10.3.10. Italy
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.3.10.3. Italy Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
      • 10.3.10.4. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
      • 10.3.10.5. Italy Market Size and Forecast, By End-use, 2019 - 2032 (US$ Billion)
    • 10.3.11. Spain
      • 10.3.11.1. Overview
      • 10.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.3.11.3. Spain Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
      • 10.3.11.4. Spain Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
      • 10.3.11.5. Spain Market Size and Forecast, By End-use, 2019 - 2032 (US$ Billion)
    • 10.3.12. The Netherlands
      • 10.3.12.1. Overview
      • 10.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.3.12.3. The Netherlands Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
      • 10.3.12.4. The Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
      • 10.3.12.5. The Netherlands Market Size and Forecast, By End-use, 2019 - 2032 (US$ Billion)
    • 10.3.13. Sweden
      • 10.3.13.1. Overview
      • 10.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.3.13.3. Sweden Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
      • 10.3.13.4. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
      • 10.3.13.5. Sweden Market Size and Forecast, By End-use, 2019 - 2032 (US$ Billion)
    • 10.3.14. Russia
      • 10.3.14.1. Overview
      • 10.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.3.14.3. Russia Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
      • 10.3.14.4. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
      • 10.3.14.5. Russia Market Size and Forecast, By End-use, 2019 - 2032 (US$ Billion)
    • 10.3.15. Poland
      • 10.3.15.1. Overview
      • 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.3.15.3. Poland Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
      • 10.3.15.4. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
      • 10.3.15.5. Poland Market Size and Forecast, By End-use, 2019 - 2032 (US$ Billion)
    • 10.3.16. Rest of Europe
      • 10.3.16.1. Overview
      • 10.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.3.16.3. Rest of the Europe Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
      • 10.3.16.4. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
      • 10.3.16.5. Rest of the Europe Market Size and Forecast, By End-use, 2019 - 2032 (US$ Billion)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. Nucleic Acid Amplification TestingKey Manufacturers in Asia Pacific
    • 10.4.3. APAC Market Size and Forecast, By Country, 2019 - 2032 (US$ Billion)
    • 10.4.4. APAC Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
    • 10.4.5. APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
    • 10.4.6. APAC Market Size and Forecast, By End-use, 2019 - 2032 (US$ Billion)
    • 10.4.7. China
      • 10.4.7.1. Overview
      • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.4.7.3. China Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
      • 10.4.7.4. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
      • 10.4.7.5. China Market Size and Forecast, By End-use, 2019 - 2032 (US$ Billion)
    • 10.4.8. India
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.4.8.3. India Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
      • 10.4.8.4. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
      • 10.4.8.5. India Market Size and Forecast, By End-use, 2019 - 2032 (US$ Billion)
    • 10.4.9. Japan
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.4.9.3. Japan Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
      • 10.4.9.4. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
      • 10.4.9.5. Japan Market Size and Forecast, By End-use, 2019 - 2032 (US$ Billion)
    • 10.4.10. South Korea
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.4.10.3. South Korea Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
      • 10.4.10.4. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
      • 10.4.10.5. South Korea Market Size and Forecast, By End-use, 2019 - 2032 (US$ Billion)
    • 10.4.11. Australia
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.4.11.3. Australia Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
      • 10.4.11.4. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
      • 10.4.11.5. Australia Market Size and Forecast, By End-use, 2019 - 2032 (US$ Billion)
    • 10.4.12. Indonesia
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.4.12.3. Indonesia Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
      • 10.4.12.4. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
      • 10.4.12.5. Indonesia Market Size and Forecast, By End-use, 2019 - 2032 (US$ Billion)
    • 10.4.13. Thailand
      • 10.4.13.1. Overview
      • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.4.13.3. Thailand Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
      • 10.4.13.4. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
      • 10.4.13.5. Thailand Market Size and Forecast, By End-use, 2019 - 2032 (US$ Billion)
    • 10.4.14. Philippines
      • 10.4.14.1. Overview
      • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.4.14.3. PhilippinesMarket Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
      • 10.4.14.4. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
      • 10.4.14.5. Philippines Market Size and Forecast, By End-use, 2019 - 2032 (US$ Billion)
    • 10.4.15. Rest of APAC
      • 10.4.15.1. Overview
      • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.4.15.3. Rest of APAC Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
      • 10.4.15.4. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
      • 10.4.15.5. Rest of APAC Market Size and Forecast, By End-use, 2019 - 2032 (US$ Billion)
  • 10.5. Latin America (LATAM)
    • 10.5.1. Overview
    • 10.5.2. Nucleic Acid Amplification Testing Key Manufacturers in Latin America
    • 10.5.3. LATAM Market Size and Forecast, By Country, 2019 - 2032 (US$ Billion)
    • 10.5.4. LATAM Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
    • 10.5.5. LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
    • 10.5.6. LATAM Market Size and Forecast, By End-use, 2019 - 2032 (US$ Billion)
    • 10.5.7. Brazil
      • 10.5.7.1. Overview
      • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.5.7.3. Brazil Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
      • 10.5.7.4. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
      • 10.5.7.5. Brazil Market Size and Forecast, By End-use, 2019 - 2032 (US$ Billion)
    • 10.5.8. Mexico
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.5.8.3. Mexico Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
      • 10.5.8.4. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
      • 10.5.8.5. Mexico Market Size and Forecast, By End-use, 2019 - 2032 (US$ Billion)
    • 10.5.9. Argentina
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.5.9.3. Argentina Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
      • 10.5.9.4. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
      • 10.5.9.5. Argentina Market Size and Forecast, By End-use, 2019 - 2032 (US$ Billion)
    • 10.5.10. Colombia
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.5.10.3. Colombia Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
      • 10.5.10.4. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
      • 10.5.10.5. Colombia Market Size and Forecast, By End-use, 2019 - 2032 (US$ Billion)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
      • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
      • 10.5.11.5. Rest of LATAM Market Size and Forecast, By End-use, 2019 - 2032 (US$ Billion)
  • 10.6. Middle East and Africa (MEA)
    • 10.6.1. Overview
    • 10.6.2. Nucleic Acid Amplification TestingKey Manufacturers in Middle East and Africa
    • 10.6.3. MEA Market Size and Forecast, By Country, 2019 - 2032 (US$ Billion)
    • 10.6.4. MEA Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
    • 10.6.5. MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
    • 10.6.6. MEA Market Size and Forecast, By End-use, 2019 - 2032 (US$ Billion)
    • 10.6.7. Saudi Arabia
      • 10.6.7.1. Overview
      • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
      • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
      • 10.6.7.5. Saudi Arabia Market Size and Forecast, By End-use, 2019 - 2032 (US$ Billion)
    • 10.6.8. UAE
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.6.8.3. UAE Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
      • 10.6.8.4. UAE Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
      • 10.6.8.5. UAE Market Size and Forecast, By End-use, 2019 - 2032 (US$ Billion)
    • 10.6.9. Israel
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.6.9.3. Israel Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
      • 10.6.9.4. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
      • 10.6.9.5. Israel Market Size and Forecast, By End-use, 2019 - 2032 (US$ Billion)
    • 10.6.10. Turkey
      • 10.6.10.1. Overview
      • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.6.10.3. Turkey Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
      • 10.6.10.4. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
      • 10.6.10.5. Turkey Market Size and Forecast, By End-use, 2019 - 2032 (US$ Billion)
    • 10.6.11. Algeria
      • 10.6.11.1. Overview
      • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.6.11.3. Algeria Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
      • 10.6.11.4. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
      • 10.6.11.5. Algeria Market Size and Forecast, By End-use, 2019 - 2032 (US$ Billion)
    • 10.6.12. Egypt
      • 10.6.12.1. Overview
      • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.6.12.3. Egypt Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
      • 10.6.12.4. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
      • 10.6.12.5. Egypt Market Size and Forecast, By End-use, 2019 - 2032 (US$ Billion)
    • 10.6.13. Rest of MEA
      • 10.6.13.1. Overview
      • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.6.13.3. Rest of MEA Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
      • 10.6.13.4. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
      • 10.6.13.5. Rest of MEA Market Size and Forecast, By End-use, 2019 - 2032 (US$ Billion)

11. Key Vendor Analysis- Nucleic Acid Amplification Testing Industry

  • 11.1. Competitive Dashboard
    • 11.1.1. Competitive Benchmarking
    • 11.1.2. Competitive Positioning
  • 11.2. Company Profiles
    • 11.2.1. Roche (F. Hoffmann-La Roche Ltd.)
    • 11.2.2. Abbott Laboratories
    • 11.2.3. Thermo Fisher Scientific Inc.
    • 11.2.4. bioMerieux
    • 11.2.5. Hologic
    • 11.2.6. QIAGEN
    • 11.2.7. Bio-Rad Laboratories
    • 11.2.8. Danaher
    • 11.2.9. Grifols S.A.
    • 11.2.10. Seegene Inc.
    • 11.2.11. Others

12. 360 Degree Analyst View

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us